Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Gains from Investment Securities (2020 - 2025)

Sight Sciences has reported Gains from Investment Securities over the past 6 years, most recently at $146000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $146000.0 for Q4 2025, up 351.72% from a year ago — trailing twelve months through Dec 2025 was $142000.0 (up 47.92% YoY), and the annual figure for FY2025 was $763751.0, down 82.89%.
  • Gains from Investment Securities for Q4 2025 was $146000.0 at Sight Sciences, down from $601217.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for SGHT hit a ceiling of $6.7 million in Q4 2021 and a floor of -$66000.0 in Q1 2023.
  • Median Gains from Investment Securities over the past 5 years was $596316.5 (2023), compared with a mean of $1.9 million.
  • Biggest five-year swings in Gains from Investment Securities: crashed 560.0% in 2023 and later soared 35338.31% in 2025.
  • Sight Sciences' Gains from Investment Securities stood at $6.7 million in 2021, then crashed by 100.45% to -$30000.0 in 2022, then surged by 320.0% to $66000.0 in 2023, then crashed by 187.88% to -$58000.0 in 2024, then skyrocketed by 351.72% to $146000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $146000.0 (Q4 2025), $601217.0 (Q3 2025), and $4.1 million (Q2 2025) per Business Quant data.